Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab in high-risk oral intraepithelial neoplasia is available, with study details, eligibility requirements, treatment arms, outcome measures, and results information. The record also includes study documents and links to related resources.
    Difference
    50%
    Check dated 2026-11-09T00:29:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T00:12:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T00:22:35.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T00:43:16.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision indicator advances from v3.7.0 to v3.7.1 while the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-12T00:28:06.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details content with a standard error screen. This indicates access to the NCT02882282 study record is blocked at the moment.
    Difference
    19%
    Check dated 2026-09-20T23:00:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.